You're argument is interesting but flawedGannonFan wrote:Sure it does. Do you really think the excise tax (i.e a tax on the sales, not a tax on profit) on medical devices won't have the effect of reducing the amount of research or innovation in that field? People like to make money from their efforts and when people see that their cannot profit from a particular line of research or innovation they tend to work on something else. Again, we have a vaccination market, globally, that doesn't really come up with new vaccinations anymore and when they do, the rollout is limited, the supply is minimal, and mostly it's because there is no way to profit from those endevours. Governments typically are the consumers in this market and they set a price and there is no competition. You get whatever they are willing to pay. It does result in real cheap vaccinations, but it also results in limited supply and a general lack of new and innovative vaccinations.Chizzang wrote:
It doesn't...
To say that we are only managing how insurance is managed is disingenious. This has never been and isn't now soley about health insurance. Medicare is basically just insurance, but its impact on the pricing and availability of medical care is pretty profound. How we treat people and medically care for people is certainly affected by the way the insurance is managed - why else would we even be discussin this issue?
If the Bio-Med industry wasn't a 500 billion dollar a year monster I'd say sure you have a point, lets not cripple this struggling delicate new micro-economy
But today
It's going to take a lot more than "Obama Care" to effect the Biomed / Pharma colossus machine
Its similar to the argument Exxon Mobil and Royal Dutch Shell use
when anybody mentions we should put environment over extraction
It's going to KILL the INDUSTRY model that's in place... and yet









